| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.36e-08 | 46 | 71 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4 | 2.16e-08 | 188 | 71 | 9 | GO:0005201 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.64e-05 | 268 | 71 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | heparin binding | 6.08e-04 | 192 | 71 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 8.04e-04 | 12 | 71 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.01e-03 | 323 | 71 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ATF6B KLF2 TBX6 | 1.36e-03 | 1244 | 71 | 12 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ATF6B KLF2 TBX6 | 1.63e-03 | 1271 | 71 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ZNF619 ATF6B KLF2 TBX6 | 1.72e-03 | 1459 | 71 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase adaptor activity | 1.84e-03 | 18 | 71 | 2 | GO:0005068 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.32e-03 | 156 | 71 | 4 | GO:0019838 | |
| GeneOntologyCellularComponent | collagen trimer | 4.95e-07 | 88 | 70 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 6.61e-07 | 21 | 70 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LTBP4 | 1.02e-05 | 530 | 70 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LGR6 LTBP4 | 1.08e-05 | 656 | 70 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LGR6 LTBP4 | 1.11e-05 | 658 | 70 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.64e-04 | 6 | 70 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.06e-04 | 8 | 70 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.06e-04 | 8 | 70 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.06e-04 | 8 | 70 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | chromatin | TFEB COPS9 SFPQ HOXC9 L3MBTL1 NFATC4 ESRRA ZBTB22 CHD3 SGF29 ATF6B DNMT1 KLF2 TBX6 | 3.38e-04 | 1480 | 70 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 7.14e-04 | 12 | 70 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 7.14e-04 | 12 | 70 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 8.56e-04 | 332 | 70 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.46e-03 | 80 | 70 | 3 | GO:0005905 | |
| HumanPheno | Glomerular basement membrane lamellation | 5.33e-05 | 3 | 22 | 2 | HP:0030034 | |
| HumanPheno | Thin glomerular basement membrane | 5.33e-05 | 3 | 22 | 2 | HP:0012577 | |
| HumanPheno | Abnormality of lens shape | 5.47e-05 | 18 | 22 | 3 | HP:0011526 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.06e-04 | 4 | 22 | 2 | HP:0012497 | |
| HumanPheno | Reduced muscle collagen VI | 1.06e-04 | 4 | 22 | 2 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 1.06e-04 | 4 | 22 | 2 | HP:0010176 | |
| HumanPheno | Increased laxity of fingers | 1.77e-04 | 5 | 22 | 2 | HP:0006149 | |
| MousePheno | sensorineural hearing loss | 1.48e-05 | 37 | 57 | 4 | MP:0004740 | |
| MousePheno | sensorineural hearing impairment | 1.65e-05 | 38 | 57 | 4 | MP:0006329 | |
| Domain | Collagen | 8.40e-07 | 85 | 71 | 6 | IPR008160 | |
| Domain | Collagen | 8.40e-07 | 85 | 71 | 6 | PF01391 | |
| Domain | TSPN | 8.83e-05 | 23 | 71 | 3 | SM00210 | |
| Domain | C4 | 2.12e-04 | 6 | 71 | 2 | SM00111 | |
| Domain | - | 2.12e-04 | 6 | 71 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.12e-04 | 6 | 71 | 2 | IPR001442 | |
| Domain | C4 | 2.12e-04 | 6 | 71 | 2 | PF01413 | |
| Domain | NC1_IV | 2.12e-04 | 6 | 71 | 2 | PS51403 | |
| Domain | TB | 2.96e-04 | 7 | 71 | 2 | PF00683 | |
| Domain | EGF_CA | 3.22e-04 | 86 | 71 | 4 | PF07645 | |
| Domain | - | 3.93e-04 | 8 | 71 | 2 | 3.90.290.10 | |
| Domain | TB | 5.04e-04 | 9 | 71 | 2 | PS51364 | |
| Domain | TB_dom | 5.04e-04 | 9 | 71 | 2 | IPR017878 | |
| Domain | EGF_Ca-bd_CS | 5.09e-04 | 97 | 71 | 4 | IPR018097 | |
| Domain | EGF_CA | 5.50e-04 | 99 | 71 | 4 | PS01187 | |
| Domain | Fib_collagen_C | 7.66e-04 | 11 | 71 | 2 | IPR000885 | |
| Domain | COLFI | 7.66e-04 | 11 | 71 | 2 | PF01410 | |
| Domain | NC1_FIB | 7.66e-04 | 11 | 71 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 7.66e-04 | 11 | 71 | 2 | PD002078 | |
| Domain | COLFI | 7.66e-04 | 11 | 71 | 2 | SM00038 | |
| Domain | EGF_CA | 1.20e-03 | 122 | 71 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.28e-03 | 124 | 71 | 4 | IPR001881 | |
| Domain | Laminin_G | 1.40e-03 | 58 | 71 | 3 | IPR001791 | |
| Domain | Growth_fac_rcpt_ | 2.95e-03 | 156 | 71 | 4 | IPR009030 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.21e-09 | 44 | 49 | 6 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.17e-08 | 61 | 49 | 6 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.09e-07 | 67 | 49 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.81e-07 | 41 | 49 | 5 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.18e-07 | 42 | 49 | 5 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.07e-07 | 46 | 49 | 5 | M198 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.99e-07 | 20 | 49 | 4 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.42e-07 | 90 | 49 | 6 | M631 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.75e-07 | 50 | 49 | 5 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.04e-06 | 53 | 49 | 5 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.50e-06 | 57 | 49 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.64e-06 | 58 | 49 | 5 | M2049 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.11e-06 | 61 | 49 | 5 | MM14637 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.49e-06 | 63 | 49 | 5 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.69e-06 | 64 | 49 | 5 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.14e-06 | 66 | 49 | 5 | M18 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.54e-06 | 74 | 49 | 5 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.32e-06 | 76 | 49 | 5 | MM14573 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.10e-06 | 300 | 49 | 8 | M610 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.72e-06 | 38 | 49 | 4 | MM14969 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.03e-05 | 84 | 49 | 5 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 IRS2 DNMT1 NRP1 | 1.17e-05 | 532 | 49 | 10 | M27870 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.83e-05 | 258 | 49 | 7 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.55e-05 | 114 | 49 | 5 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.67e-05 | 418 | 49 | 8 | MM15587 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.21e-04 | 140 | 49 | 5 | M587 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.38e-04 | 76 | 49 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.38e-04 | 76 | 49 | 4 | MM14867 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.82e-04 | 32 | 49 | 3 | MM14924 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.12e-04 | 85 | 49 | 4 | M16441 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.73e-04 | 261 | 49 | 6 | MM15676 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 5.23e-04 | 10 | 49 | 2 | MM1560 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.93e-04 | 302 | 49 | 6 | M39719 | |
| Pathway | KEGG_FOCAL_ADHESION | 6.14e-04 | 199 | 49 | 5 | M7253 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M15422 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 6.38e-04 | 11 | 49 | 2 | M27195 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 7.64e-04 | 12 | 49 | 2 | MM1526 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.84e-04 | 326 | 49 | 6 | MM15917 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 9.01e-04 | 13 | 49 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 9.01e-04 | 13 | 49 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.05e-03 | 14 | 49 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M6487 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.08e-03 | 339 | 49 | 6 | M39736 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.12e-03 | 59 | 49 | 3 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.21e-03 | 15 | 49 | 2 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.21e-03 | 15 | 49 | 2 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.75e-03 | 18 | 49 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.75e-03 | 18 | 49 | 2 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.16e-03 | 20 | 49 | 2 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.86e-03 | 23 | 49 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.86e-03 | 23 | 49 | 2 | MM1427 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.11e-03 | 24 | 49 | 2 | M47509 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.11e-03 | 24 | 49 | 2 | M519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.37e-03 | 25 | 49 | 2 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.37e-03 | 25 | 49 | 2 | M47511 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.51e-03 | 575 | 49 | 7 | M29853 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 3.93e-03 | 27 | 49 | 2 | MM15537 | |
| Pathway | WP_FOCAL_ADHESION | 3.99e-03 | 187 | 49 | 4 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.84e-03 | 30 | 49 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.84e-03 | 30 | 49 | 2 | M27216 | |
| Pubmed | 2.84e-09 | 175 | 71 | 8 | 28071719 | ||
| Pubmed | 1.24e-06 | 167 | 71 | 6 | 22159717 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.65e-06 | 544 | 71 | 9 | 28473536 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28252045 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 4.11e-06 | 2 | 71 | 2 | 28674241 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28578476 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 9537506 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 4.11e-06 | 2 | 71 | 2 | 35090027 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 29742505 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 6852033 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 38214412 | ||
| Pubmed | Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. | 4.11e-06 | 2 | 71 | 2 | 11865138 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 4.11e-06 | 2 | 71 | 2 | 17216251 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 35369551 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 1765372 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 4.11e-06 | 2 | 71 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 4.11e-06 | 2 | 71 | 2 | 16895672 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 4.11e-06 | 2 | 71 | 2 | 24052634 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19357112 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12768082 | ||
| Pubmed | Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells. | 4.11e-06 | 2 | 71 | 2 | 33982770 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25229338 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 4.11e-06 | 2 | 71 | 2 | 20029656 | |
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 4.11e-06 | 2 | 71 | 2 | 16235097 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 4.11e-06 | 2 | 71 | 2 | 15280517 | |
| Pubmed | Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4. | 4.11e-06 | 2 | 71 | 2 | 32855526 | |
| Pubmed | Ullrich disease due to deficiency of collagen VI in the sarcolemma. | 4.11e-06 | 2 | 71 | 2 | 14981181 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15880327 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12374585 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 4.11e-06 | 2 | 71 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 4.11e-06 | 2 | 71 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 4.11e-06 | 2 | 71 | 2 | 25083577 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20847057 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2551668 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18661361 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 32232700 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19309692 | ||
| Pubmed | 5.43e-06 | 17 | 71 | 3 | 1975791 | ||
| Pubmed | 6.51e-06 | 18 | 71 | 3 | 9160753 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 8.13e-06 | 62 | 71 | 4 | 28344315 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.67e-06 | 135 | 71 | 5 | 28675934 | |
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 1.23e-05 | 3 | 71 | 2 | 25204870 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.23e-05 | 3 | 71 | 2 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 1.23e-05 | 3 | 71 | 2 | 15954103 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 37188688 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 1.23e-05 | 3 | 71 | 2 | 27859054 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17396119 | ||
| Pubmed | A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. | 1.23e-05 | 3 | 71 | 2 | 24522496 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3089234 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21459131 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 36982625 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 19542202 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 1.23e-05 | 3 | 71 | 2 | 3198591 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 1.23e-05 | 3 | 71 | 2 | 28542346 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 12840783 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 28704582 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 1.23e-05 | 3 | 71 | 2 | 18366090 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.23e-05 | 3 | 71 | 2 | 30647093 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 38978054 | ||
| Pubmed | Spatial and temporal changes of type VI collagen expression during mouse development. | 1.23e-05 | 3 | 71 | 2 | 8853993 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24801232 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 33654185 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 20301386 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 16141002 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17602442 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 36130833 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.23e-05 | 3 | 71 | 2 | 38433557 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8168508 | ||
| Pubmed | Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth. | 1.23e-05 | 3 | 71 | 2 | 28619945 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7780011 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25575550 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 20301676 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 1.23e-05 | 3 | 71 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 1.23e-05 | 3 | 71 | 2 | 12011280 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3665927 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24443028 | ||
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 1.23e-05 | 3 | 71 | 2 | 15563506 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24033287 | ||
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 1.23e-05 | 3 | 71 | 2 | 9520112 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 14633121 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 32053901 | ||
| Pubmed | [Molecular mechanism of SH2B1 in regulating JAK2/IRS2 during obesity development]. | 1.23e-05 | 3 | 71 | 2 | 20360640 | |
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 1.23e-05 | 3 | 71 | 2 | 3348212 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TFEB PRR12 REPS1 GLI1 KBTBD11 STRN4 PER1 PDZD8 SNX15 IRS2 LTBP4 | 1.42e-05 | 1105 | 71 | 11 | 35748872 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.53e-05 | 908 | 71 | 10 | 19274049 | |
| Pubmed | 1.59e-05 | 153 | 71 | 5 | 25037231 | ||
| Pubmed | 1.60e-05 | 24 | 71 | 3 | 31062503 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.88e-05 | 560 | 71 | 8 | 21653829 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.46e-05 | 4 | 71 | 2 | 7827955 | |
| Pubmed | 4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass. | 2.46e-05 | 4 | 71 | 2 | 27217487 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 15611103 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 8806434 | ||
| GeneFamily | Collagens | 4.06e-09 | 46 | 53 | 6 | 490 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 5.04e-05 | 4 | 53 | 2 | 628 | |
| Coexpression | NABA_COLLAGENS | 1.79e-09 | 43 | 71 | 6 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.07e-09 | 44 | 71 | 6 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4 | 4.87e-08 | 270 | 71 | 9 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4 | 5.70e-08 | 275 | 71 | 9 | M5884 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.12e-06 | 29 | 71 | 4 | MM17055 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.20e-06 | 40 | 71 | 4 | M5887 | |
| Coexpression | LEE_BMP2_TARGETS_UP | COL4A4 COL6A1 COL6A2 SYNPO2 THBS3 WIPI1 RRAGD EFS LRP1 CHD3 LTBP4 | 7.61e-06 | 780 | 71 | 11 | M2324 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 8.79e-06 | 505 | 71 | 9 | M39167 | |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_DN | 1.02e-05 | 182 | 71 | 6 | M6641 | |
| Coexpression | LEE_BMP2_TARGETS_UP | COL4A4 COL6A1 COL6A2 SYNPO2 THBS3 WIPI1 RRAGD EFS LRP1 CHD3 LTBP4 | 1.02e-05 | 805 | 71 | 11 | MM1067 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.63e-05 | 546 | 71 | 9 | M3837 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 2.45e-05 | 21 | 71 | 3 | MM1196 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 2.83e-05 | 22 | 71 | 3 | M1627 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.67e-05 | 261 | 71 | 6 | M1834 | |
| Coexpression | ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN | 8.93e-05 | 32 | 71 | 3 | M40951 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 9.06e-05 | 681 | 71 | 9 | M39175 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 1.17e-04 | 407 | 71 | 7 | M19541 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.17e-04 | 35 | 71 | 3 | M11788 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.25e-04 | 94 | 71 | 4 | M2580 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.28e-04 | 36 | 71 | 3 | MM1212 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.31e-04 | 95 | 71 | 4 | MM1328 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T4 | 1.42e-04 | 97 | 71 | 4 | M1729 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.53e-04 | 296 | 71 | 6 | M41675 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T4 | 1.59e-04 | 100 | 71 | 4 | MM1215 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.84e-04 | 438 | 71 | 7 | M1954 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.85e-04 | 194 | 71 | 5 | M39122 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.89e-04 | 440 | 71 | 7 | MM832 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 2.03e-04 | 198 | 71 | 5 | M7948 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 2.03e-04 | 198 | 71 | 5 | M5701 | |
| Coexpression | GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 2.08e-04 | 199 | 71 | 5 | M6211 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP | 2.13e-04 | 200 | 71 | 5 | M7795 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 2.13e-04 | 200 | 71 | 5 | M4894 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 2.13e-04 | 200 | 71 | 5 | M8217 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP | 2.13e-04 | 200 | 71 | 5 | M8209 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN | 2.13e-04 | 200 | 71 | 5 | M9067 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 2.13e-04 | 200 | 71 | 5 | M9922 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 2.13e-04 | 200 | 71 | 5 | M6193 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP | 2.13e-04 | 200 | 71 | 5 | M3852 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.21e-04 | 767 | 71 | 9 | M39209 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | SYNPO2 WIPI1 GPATCH1 ZBTB22 PER1 LRP1 PCSK1N CHD3 ARHGAP27 BEGAIN | 2.40e-04 | 954 | 71 | 10 | MM3689 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL | 2.72e-04 | 115 | 71 | 4 | M45671 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 2.84e-04 | 47 | 71 | 3 | M1650 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.91e-04 | 117 | 71 | 4 | M39300 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 3.06e-04 | 337 | 71 | 6 | MM16606 | |
| Coexpression | MATZUK_PREOVULATORY_FOLLICLE | 3.21e-04 | 10 | 71 | 2 | M1827 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 3.28e-04 | 482 | 71 | 7 | M12144 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 3.83e-04 | 52 | 71 | 3 | MM693 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 3.97e-04 | 229 | 71 | 5 | MM16607 | |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_DN | 4.69e-04 | 12 | 71 | 2 | M1408 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.29e-04 | 137 | 71 | 4 | M40313 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL | 5.39e-04 | 375 | 71 | 6 | M39162 | |
| Coexpression | SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN | 5.40e-04 | 245 | 71 | 5 | M41070 | |
| Coexpression | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP | 5.53e-04 | 13 | 71 | 2 | M13055 | |
| Coexpression | ONDER_CDH1_TARGETS_1_UP | 5.59e-04 | 139 | 71 | 4 | M18757 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 6.12e-04 | 61 | 71 | 3 | M8510 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 6.19e-04 | 385 | 71 | 6 | M39264 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 1.79e-06 | 27 | 70 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 3.70e-06 | 71 | 70 | 5 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.12e-06 | 141 | 70 | 6 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.80e-05 | 455 | 70 | 9 | GSM777055_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 4.61e-05 | 395 | 70 | 8 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL4A3 COL4A4 COL6A1 COL6A2 THBS3 SFPQ HOXC9 LRP1 LTBP2 LTBP4 SCAI | 5.57e-05 | 797 | 70 | 11 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL4A4 COL6A1 COL6A2 THBS3 SFPQ HOXC9 COL27A1 LRP1 LTBP2 LTBP4 SCAI | 5.70e-05 | 799 | 70 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 5.93e-05 | 64 | 70 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.22e-04 | 234 | 70 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.45e-04 | 466 | 70 | 8 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.14e-04 | 89 | 70 | 4 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.21e-04 | 166 | 70 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.98e-04 | 97 | 70 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | COL6A1 COL6A2 ZBTB38 NFATC4 SNX18 FIBCD1 LRP1 LTBP2 NRP1 KLF2 CEMIP | 3.44e-04 | 981 | 70 | 11 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 3.66e-04 | 404 | 70 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.84e-10 | 197 | 71 | 8 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 8.22e-09 | 164 | 71 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.03e-08 | 187 | 71 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-08 | 188 | 71 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-08 | 188 | 71 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-08 | 189 | 71 | 7 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-08 | 190 | 71 | 7 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-08 | 191 | 71 | 7 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-08 | 193 | 71 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-08 | 193 | 71 | 7 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-08 | 193 | 71 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-08 | 194 | 71 | 7 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.62e-08 | 194 | 71 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-08 | 194 | 71 | 7 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-08 | 194 | 71 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-08 | 194 | 71 | 7 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.71e-08 | 195 | 71 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.71e-08 | 195 | 71 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-08 | 197 | 71 | 7 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-08 | 197 | 71 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-08 | 198 | 71 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-08 | 198 | 71 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-08 | 198 | 71 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.01e-08 | 198 | 71 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.23e-08 | 200 | 71 | 7 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.23e-08 | 200 | 71 | 7 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-08 | 200 | 71 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-08 | 200 | 71 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.23e-08 | 200 | 71 | 7 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.23e-08 | 200 | 71 | 7 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.23e-08 | 200 | 71 | 7 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.23e-08 | 200 | 71 | 7 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-08 | 200 | 71 | 7 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-08 | 200 | 71 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-07 | 171 | 71 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-07 | 178 | 71 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 181 | 71 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 181 | 71 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-07 | 181 | 71 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.65e-07 | 182 | 71 | 6 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 184 | 71 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 185 | 71 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 185 | 71 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-07 | 186 | 71 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-07 | 186 | 71 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.44e-07 | 187 | 71 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-07 | 187 | 71 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.79e-07 | 189 | 71 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-07 | 189 | 71 | 6 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 5.97e-07 | 190 | 71 | 6 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.16e-07 | 191 | 71 | 6 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.16e-07 | 191 | 71 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.16e-07 | 191 | 71 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-07 | 192 | 71 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-07 | 192 | 71 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-07 | 192 | 71 | 6 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 192 | 71 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-07 | 192 | 71 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-07 | 192 | 71 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.35e-07 | 192 | 71 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 192 | 71 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.35e-07 | 192 | 71 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-07 | 192 | 71 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.35e-07 | 192 | 71 | 6 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-07 | 192 | 71 | 6 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.35e-07 | 192 | 71 | 6 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-07 | 192 | 71 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 6.55e-07 | 193 | 71 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-07 | 193 | 71 | 6 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-07 | 193 | 71 | 6 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 193 | 71 | 6 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.75e-07 | 194 | 71 | 6 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-07 | 194 | 71 | 6 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 6.75e-07 | 194 | 71 | 6 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.75e-07 | 194 | 71 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-07 | 194 | 71 | 6 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-07 | 194 | 71 | 6 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-07 | 194 | 71 | 6 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.75e-07 | 194 | 71 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-07 | 194 | 71 | 6 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 6.75e-07 | 194 | 71 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.95e-07 | 195 | 71 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.95e-07 | 195 | 71 | 6 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| Computational | Neighborhood of CDH11 | 1.58e-04 | 25 | 46 | 3 | GNF2_CDH11 | |
| Drug | GK-101 | 8.94e-08 | 36 | 71 | 5 | CID000161853 | |
| Drug | Madecassol | 3.17e-07 | 46 | 71 | 5 | CID000108062 | |
| Drug | d-indobufen | 4.86e-07 | 50 | 71 | 5 | CID000044562 | |
| Drug | ridogrel | 5.93e-07 | 52 | 71 | 5 | CID005362391 | |
| Drug | NSC49633 | 6.53e-07 | 53 | 71 | 5 | CID000023340 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.14e-06 | 173 | 71 | 7 | 995_UP | |
| Drug | AC1L1C2F | 1.23e-06 | 110 | 71 | 6 | CID000001711 | |
| Drug | AC1LAKND | 1.44e-06 | 62 | 71 | 5 | CID000470146 | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.86e-06 | 186 | 71 | 7 | 3178_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.37e-06 | 193 | 71 | 7 | 4670_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.54e-06 | 195 | 71 | 7 | 3712_UP | |
| Drug | Selara | 2.60e-06 | 125 | 71 | 6 | CID000150310 | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.63e-06 | 196 | 71 | 7 | 3830_DN | |
| Drug | BAPN | 2.84e-06 | 71 | 71 | 5 | CID000001647 | |
| Drug | malotilate | 2.84e-06 | 71 | 71 | 5 | CID000004006 | |
| Drug | AC1NMZ1B | 3.72e-06 | 75 | 71 | 5 | CID005034185 | |
| Drug | strontium ranelate | 4.24e-06 | 77 | 71 | 5 | CID006918182 | |
| Drug | candesartan cilexetil | 6.13e-06 | 145 | 71 | 6 | CID000002540 | |
| Drug | halofuginone lactate | 6.91e-06 | 85 | 71 | 5 | CID000062891 | |
| Drug | AC1Q6PCP | 7.52e-06 | 230 | 71 | 7 | CID000005267 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.32e-06 | 156 | 71 | 6 | 1010_UP | |
| Drug | 4-hydroxyproline | 9.65e-06 | 91 | 71 | 5 | CID000000825 | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.52e-05 | 170 | 71 | 6 | 965_UP | |
| Drug | ticlopidine | 1.77e-05 | 103 | 71 | 5 | CID000005472 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.10e-05 | 180 | 71 | 6 | 7356_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.31e-05 | 183 | 71 | 6 | 6985_UP | |
| Drug | hydroxylysine | 2.32e-05 | 109 | 71 | 5 | CID000001029 | |
| Drug | PPACK | 2.76e-05 | 113 | 71 | 5 | CID003036757 | |
| Drug | AC1L9732 | 2.88e-05 | 114 | 71 | 5 | CID000439300 | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 2.93e-05 | 191 | 71 | 6 | 2368_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 2.93e-05 | 191 | 71 | 6 | 1665_UP | |
| Drug | Tranilast sodium | 3.01e-05 | 115 | 71 | 5 | CID000005527 | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.02e-05 | 192 | 71 | 6 | 2807_UP | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 2078_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 3370_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 3378_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 5665_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 6062_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3732_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 4739_DN | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 5948_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 3401_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 6765_UP | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 4351_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 2636_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 1519_UP | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 3.59e-05 | 198 | 71 | 6 | 123_UP | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 4372_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.80e-05 | 200 | 71 | 6 | 7480_UP | |
| Drug | DMSe | 5.82e-05 | 132 | 71 | 5 | CID000020796 | |
| Drug | pirfenidone | 7.18e-05 | 138 | 71 | 5 | CID000040632 | |
| Drug | DL-penicillamine | 7.43e-05 | 139 | 71 | 5 | CID000004727 | |
| Drug | PCR 4099 | 7.43e-05 | 139 | 71 | 5 | CID000002806 | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 157 | 71 | 5 | 2651_UP | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.48e-04 | 161 | 71 | 5 | 2227_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.53e-04 | 162 | 71 | 5 | 5018_UP | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.53e-04 | 162 | 71 | 5 | CID000072363 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.66e-04 | 165 | 71 | 5 | 5227_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | 1.76e-04 | 167 | 71 | 5 | 5212_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.81e-04 | 168 | 71 | 5 | 1649_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A | 1.97e-04 | 171 | 71 | 5 | 2429_DN | |
| Drug | khellin | 1.97e-04 | 171 | 71 | 5 | CID000003828 | |
| Drug | AC1L9HPX | 1.97e-04 | 92 | 71 | 4 | CID000445279 | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A | 2.08e-04 | 173 | 71 | 5 | 4617_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.37e-04 | 178 | 71 | 5 | 5234_UP | |
| Drug | AC1L1DD6 | 2.43e-04 | 179 | 71 | 5 | CID000002299 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.49e-04 | 180 | 71 | 5 | 5584_UP | |
| Drug | Benzethonium chloride [121-54-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.49e-04 | 180 | 71 | 5 | 6070_UP | |
| Drug | Rifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 181 | 71 | 5 | 4349_UP | |
| Drug | silibinin | 2.64e-04 | 285 | 71 | 6 | CID000005213 | |
| Drug | Pcme | 2.65e-04 | 8 | 71 | 2 | CID000169849 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.69e-04 | 183 | 71 | 5 | 4732_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.90e-04 | 186 | 71 | 5 | 4163_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.97e-04 | 187 | 71 | 5 | 3037_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.97e-04 | 187 | 71 | 5 | 1242_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 2.97e-04 | 187 | 71 | 5 | 5678_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.97e-04 | 187 | 71 | 5 | 3386_UP | |
| Drug | chondroitin sulfate | 3.01e-04 | 413 | 71 | 7 | CID000024766 | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; PC3; HT_HG-U133A | 3.05e-04 | 188 | 71 | 5 | 7397_UP | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.12e-04 | 189 | 71 | 5 | CID000001413 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.12e-04 | 189 | 71 | 5 | 882_UP | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 3.16e-04 | 104 | 71 | 4 | ctd:C000595015 | |
| Drug | foscarnet | 3.20e-04 | 190 | 71 | 5 | CID000003414 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.20e-04 | 190 | 71 | 5 | 5602_UP | |
| Drug | Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 2955_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 3905_UP | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 3448_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.28e-04 | 191 | 71 | 5 | 4791_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 4795_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 3340_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 3.44e-04 | 193 | 71 | 5 | 5633_DN | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6883_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 2775_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 5531_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 4082_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 4559_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 5695_UP | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.52e-04 | 194 | 71 | 5 | 6076_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 6330_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.61e-04 | 195 | 71 | 5 | 4180_DN | |
| Disease | benign familial hematuria (is_implicated_in) | 5.23e-06 | 2 | 68 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 5.23e-06 | 2 | 68 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 5.23e-06 | 2 | 68 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 5.23e-06 | 2 | 68 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 5.23e-06 | 2 | 68 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 5.23e-06 | 2 | 68 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 5.23e-06 | 2 | 68 | 2 | cv:C0241908 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 1.57e-05 | 3 | 68 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.57e-05 | 3 | 68 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 3.13e-05 | 4 | 68 | 2 | C0241908 | |
| Disease | Bethlem myopathy (is_implicated_in) | 3.13e-05 | 4 | 68 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 3.13e-05 | 4 | 68 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 3.13e-05 | 4 | 68 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 3.13e-05 | 4 | 68 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 3.13e-05 | 4 | 68 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | MRNA-decapping enzyme 1A measurement | 3.13e-05 | 4 | 68 | 2 | EFO_0802757 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 3.13e-05 | 4 | 68 | 2 | C0410179 | |
| Disease | Alport Syndrome | 3.13e-05 | 4 | 68 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 5.21e-05 | 5 | 68 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 5.21e-05 | 5 | 68 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 5.21e-05 | 5 | 68 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 7.80e-05 | 6 | 68 | 2 | C0848548 | |
| Disease | refractive error | 1.07e-04 | 326 | 68 | 6 | MONDO_0004892 | |
| Disease | MiT family translocation renal cell carcinoma | 1.09e-04 | 7 | 68 | 2 | C4518356 | |
| Disease | response to ondansetron, QT interval | 2.84e-04 | 11 | 68 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | collagen disease (implicated_via_orthology) | 3.40e-04 | 12 | 68 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | central corneal thickness | 7.41e-04 | 309 | 68 | 5 | EFO_0005213 | |
| Disease | urate measurement | 1.03e-03 | 895 | 68 | 8 | EFO_0004531 | |
| Disease | carpal tunnel syndrome | 1.15e-03 | 89 | 68 | 3 | EFO_0004143 | |
| Disease | Renal glomerular disease | 1.28e-03 | 23 | 68 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.28e-03 | 23 | 68 | 2 | C4521256 | |
| Disease | hematocrit | 2.22e-03 | 1011 | 68 | 8 | EFO_0004348 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEEGGDEGGSGYSPP | 121 | O94986 | |
| EGAGPYVDLDEAGGS | 11 | Q8WXC6 | |
| ESYGSEKGAPGDPGL | 281 | Q01955 | |
| GDKGEPGYSEGTRPG | 1051 | Q01955 | |
| PIYDDDPSLEGGVNG | 441 | P26358 | |
| PGYAPSEGGDGDRLG | 511 | Q9BUH8 | |
| DPGFPGRYGETGDVG | 371 | P53420 | |
| LAGDVDERGGYDPPT | 561 | Q8WUJ3 | |
| KSYPAGGEAGGEEPE | 656 | Q6UXK2 | |
| DAYPGRRADCGPGEG | 121 | P31274 | |
| FRLEPGGSPSDEGDY | 101 | Q8IVU1 | |
| EASEAGRPPGLETYG | 881 | Q9HBX8 | |
| YEGGEPDDVGGLLDA | 4476 | Q07954 | |
| PPGSSEGSEGEDDDY | 196 | Q9BRR8 | |
| EGADGGGDPRPGESF | 6 | O15534 | |
| YDDGPAGPDAEEAGD | 171 | Q9UHG2 | |
| TEYEDGGAPAGDGEA | 126 | Q9Y468 | |
| YGGGRDEEPSGAAPE | 61 | Q8NEN9 | |
| RFQAEEYGEGGTDPP | 326 | P13942 | |
| EGGGREDAPAQEPSY | 911 | P08151 | |
| AGGGYRLGAAPEEES | 151 | Q9UNZ2 | |
| ETGSTPGYEGEGEGD | 826 | O14786 | |
| GYGEAGVDGEVPGSA | 451 | O95302 | |
| ETPPARDGGGGGEFY | 526 | Q9Y4H2 | |
| GYRGDEGPPGSEGAR | 476 | P12109 | |
| GYPGLKGDEGEAGDP | 541 | P12109 | |
| GGSYVFQSDEGPEPE | 306 | Q12873 | |
| YPGEAGSPGERGDQG | 356 | P12110 | |
| GGVAAEPDGGEGRYP | 231 | F5H4A9 | |
| GPGVETYPDGSQDVG | 81 | Q9P2S6 | |
| VGDRGDRGEPGDPGY | 1351 | Q8IZC6 | |
| GYGGPKVEGDPEGRE | 346 | O43281 | |
| DGGYRPSPLGDSCED | 1121 | Q14767 | |
| GQSPGEEGYVPDADI | 276 | Q96T53 | |
| FEDDGGPYGESEAPA | 1476 | Q8N2S1 | |
| GVGLFSVDPEEDGYP | 351 | Q8N539 | |
| YGDGPDSSDADPDSG | 31 | Q9NQL2 | |
| EYEAGRAGPGGGAER | 361 | P11474 | |
| QDFGPGYSDEEPDPG | 2131 | Q01668 | |
| ELPYDPVDTEGFGEG | 51 | Q8NC60 | |
| VGGGSPEREEVGAGY | 161 | Q96G74 | |
| IEVYDPGSEDPRGTG | 71 | A6ND36 | |
| ERSPPSGGGGYELRE | 746 | P84550 | |
| GEPEGGEGDQPLSGY | 511 | Q9NRF2 | |
| SFGGREDEGPPGYPE | 401 | P19484 | |
| GDQPGEVGYSGSPAE | 381 | Q96D71 | |
| GYGPGEGAPEQEKSR | 846 | Q14934 | |
| EELRGYDSGPEGGAA | 1131 | Q9H6K5 | |
| PEEDYSPVGSFGEPG | 371 | Q6ZUM4 | |
| GGAADDYGKAGPPED | 956 | Q9ULL5 | |
| SPSRGGPDDDGGYTA | 121 | O75526 | |
| EPFESYGELRGAAPG | 281 | O75526 | |
| YPGTEPGAAGESESE | 11 | O94819 | |
| PNETLSGRGAPGDYE | 626 | Q99941 | |
| PPGFGGTGEDYSEEG | 306 | Q9NRU3 | |
| GTPAGYGRGREEYEG | 686 | P23246 | |
| YGLSEGEAAGRPAGP | 41 | Q9UID3 | |
| RGTGAGGDSGPEEDY | 721 | Q9UMS6 | |
| GAIPASGDYVARPGD | 146 | Q96ES7 | |
| DEPGALGSGAYPDLD | 166 | Q96RF0 | |
| VPEEANGPGGGYDLR | 236 | Q99469 | |
| EEEDGEGGPTPAYLS | 256 | Q9NRS6 | |
| GVFPTGRSDSEGPYD | 371 | Q8N9R8 | |
| RGPEPAATEAYGSGD | 291 | O95947 | |
| GDDDNDGIPDYVPPG | 661 | P49746 | |
| GGVPAGSDEYEDECP | 436 | Q9BVS4 | |
| FLGSGEDGEGAPDPR | 321 | Q9NRL3 | |
| GEIPEESNYVADPGG | 786 | Q8NAP3 | |
| VPGYSEDGGALRGEV | 396 | Q5MNZ9 | |
| DTPYEPAEGGPRAEG | 291 | Q5VZ18 | |
| PYAEGPIQGGDAGEL | 6 | Q8N2I2 | |
| PYEGGGPVAGLDDSG | 386 | O15209 | |
| GGKGEERYAEAGPAP | 196 | Q9BXU2 | |
| VKAEPPEADGGGGYG | 121 | Q9Y5W3 |